Biggest Pharma Deal Ever Propels Bristol-Myers to No. 1 in Cancer Market

Bookmark
(Bloomberg) -- Bristol-Myers Squibb Co.’s $74 billion planned purchase of Celgene Corp. puts it in line to lead the drug industry’s hottest market, cancer, as early as next year.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.